UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Aravive is implementing good security practices.
Aravive, Inc., is a clinical stage biotechnology company focused on developing new therapies that target important survival pathways for both solid tumors as well as hematologic malignancies.
This report shows a preliminary security rating for Aravive. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
While over 70 percent of global employees work remotely at least once per week and full-time remote ...
Today, cybersecurity and vendor risk management are a top priority not only for CISOs but senior ...
Compare Aravive's security performance with other companies